Home
Conditions
Digestive System Neoplasms

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,230 public trials 3,233 recruiting studies

Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, Not Recruiting

Combination Immunotherapy in Colorectal Cancer

NCT05571293

Conditions: Colonic Diseases, Colorectal Neoplasms, Diabetes Mellitus, Insulin-Dependent, 12, +9 more
Locations: Weill Cornell Medicine/New York-Presbyterian Brooklyn Methodist Hospital Brooklyn, New York, United States

Weill Cornell Medicine/NewYork Presbyterian - Queens Flushing, New York, United States

Weill Cornell Medicine/NewYork-Presbyterian Hospital New York, United States

View Trial Details

Active, Not Recruiting

PD-1 Inhibitor INCMGA00012 as Consolidation Therapy After Definitive Concurrent Chemoradiotherapy

NCT04494009

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +7 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Active, Not Recruiting

Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer

NCT04503694

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Institut Jules Bordet Anderlecht, Belgium

Chirec Delta Brussels, Belgium

Cliniques Universitaires Saint-Luc Brussels, Belgium

UZAntwerpen Edegem, Belgium

View Trial Details

Active, Not Recruiting

NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer

NCT04484909

Conditions: Borderline Resectable Pancreatic Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers

NCT04196465

Conditions: Digestive System Diseases, Digestive System Neoplasms, Liver Diseases, +6 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Active, Not Recruiting

Bevacizumab Plus mFOLFOXIRI as First-line Treatment for Patients With Unresectable Metastatic Colorectal Cancer

NCT04230187

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations: Gastrointestinal Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

PAnitumumab REchallenge Followed by REgorafenib Versus the Reverse Sequence

NCT04787341

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations: U.O. Oncologia 2 Universitaria Pisa, PI, Italy

View Trial Details

Active, Not Recruiting

Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC

NCT05546879

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: CHU de GRENOBLE ALPES Grenoble, Alpes, France

CHU Angers Angers, France

Hôpital Haut Lêveque Bordeaux, France

12 Hôpital St Joseph Marseille, France

View Trial Details

Active, Not Recruiting

PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer

NCT03187951

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Intraoperative Use of Oxygen Saturation Imaging to Assess Intestinal Perfusion

NCT07587619

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +10 more
Locations: University of Southern California Los Angeles, California, United States

View Trial Details

Digestive System Neoplasms

Digestive System Neoplasms trial results

Related conditions